PBP-3 directed therapy in VIM-producing Pseudomonas aeruginosa creates bacterial transformers, persisters in disguise
-
Published:2024-09
Issue:3
Volume:64
Page:107260
-
ISSN:0924-8579
-
Container-title:International Journal of Antimicrobial Agents
-
language:en
-
Short-container-title:International Journal of Antimicrobial Agents
Author:
Smith Nicholas M.ORCID,
Boissonneault Katie Rose,
Holden Patricia N.,
Kaur Jan Naseer,
Klem Jack F.ORCID,
Cha Raymond,
Sutton Mark D.ORCID,
Tsuji Brian T.
Reference44 articles.
1. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis;Tacconelli;Lancet Infect Dis,2018
2. Antibiotic Resistance Threats in the United States 2019,2019
3. The versatile mutational resistome of Pseudomonas aeruginosa;López-Causapé;Front Microbiol,2018
4. Pseudomonas aeruginosa lifestyle: A paradigm for adaptation, survival, and persistence;Moradali;Front Cell Infect Microbiol,2017
5. Tolerance and persistence of Pseudomonas aeruginosa in biofilms exposed to antibiotics: Molecular mechanisms, antibiotic strategies and therapeutic perspectives;Soares;Front Microbiol,2020